Skip to main content
Clinical Trials/TCTR20210615001
TCTR20210615001
Active, Not Recruiting
N/A

The comparison of intraoperative arterial blood pressure lability during general anesthesia in treated hypertensive patients who have controlled blood pressure based on office measurement (Masked uncontrolled hypertensive VS adequate blood pressure controlled patients)

Faculty of Medicine, Prince of Songkla University0 sites117 target enrollmentJune 15, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
- arterial blood pressure lability- general anesthesia- masked uncontrolled hypertension- perioperative complications
Sponsor
Faculty of Medicine, Prince of Songkla University
Enrollment
117
Status
Active, Not Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 15, 2021
End Date
June 30, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Faculty of Medicine, Prince of Songkla University

Eligibility Criteria

Inclusion Criteria

  • 1\. Adult patients who are older than or equal to 18 years
  • 2\. Patients who have been diagnosed as hypertension and are currently under treatment and also have controlled blood pressure based on office measurement
  • 3\. Patients who are scheduled and undergo for elective non\-cardiac surgery, including intraabdominal and intrapelvic surgery under general anesthesia
  • 4\. Patient's data will be collected from only the first occasion of undergoing general anesthesia after enrollment

Exclusion Criteria

  • 1\.Patients who are scheduled for elective cardiac surgery under general anesthesia.
  • 2\.Patients who are scheduled for emergency non\-cardiac surgery under general anesthesia.
  • 3\.Patients who have underlying diseases or history of severe cardiac problems e.g. severe valvular heart disease, heart failure, myocardial infarction with poor cardiac output, LVEF less than 35 percentage or functional class III\-IV by New York Heart Association.
  • 4\.Patients who have underlying diseases or history of pheochromocytoma or mass at adrenal grand.
  • 5\.Patients who have underlying diseases or history of increased intracranial pressure.
  • 6\.Patients who have underlying diseases or history of end stage renal failure, hemodialysis or peritoneal dialysis therapy.
  • 7\.Patients who have underlying diseases or history of vascular diseases e.g. aortic aneurysm, arterial occlusion.
  • 8\.Patients with pregnancy.
  • 9\.Patients who decline to provide informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials